Focus on the BIG picture.
Thursday, Jul 17, 2025

0:00
0:00

U.S. Clinical Study Investigates Medication to Prolong Dogs' Lifespan

The San Francisco-based firm Loyal is carrying out an extensive study to evaluate the impacts of a possible longevity medication for older dogs.
A clinical trial is currently being conducted in the United States to assess a drug that could potentially prolong the lifespan of dogs.

Called the STAY trial, this study is spearheaded by Loyal, an animal health company based in San Francisco.

This double-blind, placebo-controlled trial involves a minimum of one thousand senior dogs, with the aim of obtaining approval from the U.S. Food and Drug Administration (FDA) based on the results.

The trial follows promising preclinical and pilot studies.

As explained by Alex Robb, medical director at Goodheart Animal Health Center in Colorado, the participating dogs will receive daily doses of the drug over a four-year period, accompanied by regular clinical evaluations.

Researchers will assess whether the drug has a noticeable effect on longevity upon the study's completion.

To be eligible for the trial, dogs must be at least ten years old and weigh a minimum of fourteen pounds.

Owners must agree to transfer their pet's primary care to a study clinic involved in the trial and commit to multiple veterinary visits throughout the four years.

The initial year requires six visits, followed by two visits each year thereafter.

The study aims to explore factors contributing to canine aging, such as their higher metabolic rate compared to humans.

While veterinary advancements have enhanced healthcare for dogs, their overall lifespan has not increased proportionally to human lifespans.

Loyal intends to use the data gathered to apply for conditional FDA approval of the drug by the end of the year.

Recruitment for the study is currently ongoing at various clinics nationwide.
Newsletter

Related Articles

0:00
0:00
Close
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
House GOP Blocks Second Democratic Bid to Release Epstein Documents
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Jeff Bezos Considers Purchasing Condé Nast as a Wedding Gift
Provocative Times Square Billboard Urges New Yorkers to ‘Move to Ohio’ Over Mamdani
Ghislaine Maxwell Says She’s Ready to Testify Before Congress on Epstein’s Criminal Empire
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
Google Secures Windsurf AI Coding Team in $2.4 Billion Licence Deal
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
Nvidia CEO Claims Chinese Military Reluctance to Use US AI Technology
Australia Rules Out Pre‑commitment of Troops, Reinforces Defence Posture Amid US‑China Tensions
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
U.S. Resumes Deportations to Third Countries After Supreme Court Ruling
Lawmakers Report Overcrowded Conditions at Florida's 'Alligator Alcatraz' Detention Facility
Taiwan’s Distant‑Water Fishing Industry Under Scrutiny for Migrant Worker Abuse
Iranian President Reportedly Injured During Israeli Strike on Secret Facility
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Defends Attorney General Pam Bondi Amid Epstein Memo Backlash
If the Department is Really About Justice: Ghislaine Maxwell Should Be Freed Now
NYC Candidate Zohran Mamdani’s ‘Antifada’ Remarks Spark National Debate on Political Language and Economic Policy
GAO Report Identifies Major Failures by Secret Service Ahead of Trump Rally Shooting
President Trump Visits Flood-Ravaged Texas, Praises Community Strength and First Responders
From Mystery to Meltdown, Crisis Within the Trump Administration: Epstein Files Ignite A Deepening Rift at the Highest Levels of Government Reveals Chaos, Leaks, and Growing MAGA Backlash
Trump Slams Putin Over War Death Toll, Teases Major Russia Announcement
Reparations argument crushed
Rainmaker CEO Says Cloud Seeding Paused Before Deadly Texas Floods
A 92-year-old woman, who felt she doesn't belong in a nursing home, escaped the death-camp by climbing a gate nearly 8 ft tall
French Journalist Acquitted in Controversial Case Involving Brigitte Macron
Elon Musk’s xAI Targets $200 Billion Valuation in New Fundraising Round
Kraft Heinz Considers Splitting Off Grocery Division Amid Strategic Review
Trump Proposes Supplying Arms to Ukraine Through NATO Allies
U.S. State Department Initiates Layoffs of Over 1,300 Employees
EU Proposes New Tax on Large Companies to Boost Budget
Trump Imposes 35% Tariffs on Canadian Imports Amid Trade Tensions
Trump Administration Targets Chinese Influence in Agriculture
US Opens First Rare Earth Mine in Over 70 Years in Wyoming
Kurdistan Workers Party Takes Symbolic Step Towards Peace in Northern Iraq
Bitcoin Reaches New Milestone of $116,000
Biden’s Doctor Pleads the Fifth to Avoid Self-Incrimination on President’s Medical Fitness
Grok Chatbot Faces International Backlash for Antisemitic Content
Severe Heatwave Claims 2,300 Lives Across Europe
NVIDIA Achieves Historic Milestone as First Company Valued at $4 Trillion
Declining Beer Consumption Signals Cultural Shift in Germany
Linda Yaccarino Steps Down as CEO of X After Two Years
US Imposes New Tariffs on Brazilian Exports Amid Political Tensions
×